EUPRAXIA PHARMACEUTICALS INC.
EPRX · XNASCIK 1581178fmd_1WPZ289ZX4JR32KR2TT327TV4VManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2022 to Dec 31, 2025, 4 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 0 |
| Research and development | 14 | 20 | 16 | 21 |
| Compensation and benefits | 2 | 2 | 3 | 4 |
| Total operating expenses | 18 | 28 | 27 | 38 |
| Interest expense | 1 | 1 | 1 | 0 |
| Interest and investment income | 0 | 1 | 1 | 1 |
| Other non-operating income (expense) | (1) | (1) | 1 | (0) |
| Income before taxes | (19) | (29) | (26) | (39) |
| Income tax expense | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (19) | (28) | (26) | (41) |
| Net income | (18) | (28) | (26) | (39) |